Antitumor and Antimetastatic Activities of 4-Hydroxyderricin Isolated from Angelica keiskei Roots

Abstract

The roots of Angelica keiskei Koizumi (Umbelliferae) have traditionally been used as a health food considered to have diuretic, laxative, analeptic and lactagogue effects. Recently, it has been thought that the roots and herbs of A. keiskei have preventive effects against coronary heart disease, hypertension and cancer. It has been reported that chalcone derivatives, such as xanthoangelol and 4-hydroxyderricin, are isolated as main components from this root. Recently, we reported that the 50 % ethanol extract, the ethyl acetate-soluble fraction and the isolated xanthoangelol, inhibited tumor growth and metastasis to the lung in Lewis lung carcinoma (LLC)-bearing mice. In the present study, we examined the effects of 4-hydroxyderricin on tumor growth and metastasis to the lung or liver in subcutaneous or intrasplenic LLC-implanted C57BL/6J female mice. 4-Hydroxyderricin at a dose of 50 mg/kg × 2/day orally inhibited the tumor growth in subcutaneous LLC-implanted mice and inhibited the lung metastasis and prolonged the survival time in mice after the removal of subcutaneous tumors by surgical operation. Doxorubicin (5 mg/kg × 2/week, i. p.) inhibited the tumor growth and metastasis to the lung, but it shortened the survival time and reduced the survival rate compared to those in 4-hydroxyderricin-treated mice. 4-Hydroxyderricin inhibited DNA synthesis in LLC cells at a concentration of 100 μM, but it had no effect on the DNA synthesis in human umbilical vein endothelial cells (HUVECs) or on the adherence of LLC cells to HUVECs. 4-Hydroxyderricin inhibited Matrigel-induced formation of capillary-like tubes by HUVECs at concentrations of 10 to 100 μM. The weights of the spleen and thymus in mice with subcutaneously implanted LLC were maintained close to those of normal mice by orally administered 4-hydroxyderricin. In addition, 4-hydroxyderricin (50 mg/kg × 2/day) inhibited the reduction of the numbers of lymphocytes, CD4⁺, CD8⁺ and natural killer (NK)-T cells in the spleen of tumor-removed mice. Doxorubicin reduced the numbers of lymphocytes, CD4⁺, CD8⁺ and NK cells compared to those in LLC-removed mice. These results suggest that the antitumor and antimetastatic activities of 4-hydroxyderricin may be modulated by the immune system and the inhibition of angiogenesis.

Antitumor activity - antimetastatic activity - 4-hydroxyderricin - Angelica keiskei - Umbelliferae

References

• 1 Hata K, Kozawa M. Pharmacological studies on Umbelliferous plants XVIII. On the constituents of the roots of Angelica keiskei Koidzumi.  Yakugaku Zasshi. 1961;  81 1647-9
• 2 Kozawa M, Morita N, Baba K, Hata K. The structure of xanthangelol, a new chalcone from the roots of Angelica keiskei Koidzumi (Umbelliferae).  Chem Pharm Bull (Tokyo). 1977;  25 515-6
• 3 Kozawa M, Morita N, Baba K, Hata K. Chemical components of the roots of Angelica keiskei Koidzumi. II. The structure of the chalcone derivatives.  Yakugaku Zasshi (In Japanese). 1978;  98 210-4
• 4 Matsuura M, Kimura Y, Nakata K, Baba K, Okuda H. Artery relaxation by chalcones isolated from the roots of Angelica keiskei .  Planta Med. 2001;  67 230-5
• 5 Gorelik E, Segal S, Feldman M. Growth of local tumor exerts a specific inhibitory effect on progression of lung metastases.  Int J Cancer. 1978;  21 617-25
• 6 Gorelik E, Segal S, Feldman M. Control of lung metastasis progression in mice: Role of growth kinetics of 3LL Lewis lung carcinoma and host immune activity.  J Nat Cancer Inst. 1980;  65 1257-64
• 7 Hasegawa H, Saiki I. Oleoyl triterpene glycoside biotransformed from ginseng suppresses growth and metastasis of murine B16-F10 melanoma via immunostimulation.  J Trad Med. 2000;  17 186-93
• 8 Kimura Y. Carp oil or oleic acid but linoleic acid or linolenic acid, inhibits tumor growth and metastasis in Lewis lung carcinoma-bearing mice.  J Nutr. 2002;  132 2069-75
• 9 Glaces D, Weiss L. Initial arrest patterns of circulating cancer cells: Effects of host sensitization and anticoagulation. In: Weiss L. ed Fundamental Aspects of Metastasis. Amsterdam, North-Holland; 1976: 263-73
• 10 Hock H, Dorsch M, Kunzendorf Y, Quin Z, Diamanstein T, Blanskenstein T. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ.  Proc Natl Acad Sci USA. 1993;  90 2774-8
• 11 Hung K, Hayashi R, Lafond-Walker A, Lowebstein C, Pardoll D, Levisky H. The central role of CD4⁺; T cells in the antitumor immune response.  J Exp Med. 1998;  188 2357-68
• 12 Segal B M, Glass D D, Sgevach E M. Cutting edge: IL-10-producing CD4⁺ T cells mediate tumor rejection.  J Immunol. 2002;  168 1-4
• 13 Colomno H P, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?.  Immuno Today. 1994;  15 48-51
• 14 Ma H -L, Whitters M J, Konz R F, Senices M, Young D A, Grusby M J, Collins M, Dunussi-Joannopoulos K. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-γ.  J Immunol. 2003;  171 608-15
• 15 Kimura Y, Baba K. Antitumor and antimetastaic activities of Angelica keisekei roots (Part 1) Isolation of an active substance, xanthoangelol.  Int J Cancer. 2003;  106 429-37
• 16 Kimura Y, Okuda H. Effects of naturally occurring stilbene glycoside from medicinal plants and wine, on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice.  J Pharm Pharmacol. 2000;  52 1287-95
• 17 Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum roots prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice.  J Nutr. 2001;  131 1844-9
• 18 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases.  Nature Med. 1995;  1 27-31
• 19 O’Reilly M S, Boem T, Shing Y, Fukai N, Vasios G, Lane W S, Flynn E, Birkhead J R, Olsen B R, Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth.  Cell. 1997;  88 277-85
• 20 Folkman J, Klagsbrum M. Angiogenic factors.  Science. 1987;  235 442-7